KalVista launched Ekterly in the U.S. in July for the treatment of acute attacks of hereditary angioedema in adults and ...

KalVista reports early EKTERLY sales momentum, rising prescriber adoption and global regulatory approvals following the drug's 2025 launch.

Patients with hereditary angioedema using deucrictibant as an on-demand treatment for attacks achieved onset of symptom ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided its preliminary fourth quarter and full year ended December 31, ...

Hereditary angioedema (HAE) is a serious, potentially fatal disease of recurrent swelling of various subcutaneous and submucosal tissues throughout the body. Swelling is mediated by uncontrolled ...

Please provide your email address to receive an email when new articles are posted on . The patient, aged 66 years, had no previous edema. The patient tested positive for a mutation in the plasminogen ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A single dose of ...

Hereditary angioedema (HAE) is a genetic condition that causes bouts of swelling in the tissue under your skin. The uncomfortable swelling can happen in many different parts of your body, including ...

Hereditary angioedema (HAE) is a condition that causes repeated attacks of painful swelling. The swelling most often affects the skin, digestive tract, and upper airway (tongue, throat, and larynx).

Hereditary angioedema (HAE) is a rare genetic condition that causes episodes of pronounced swelling in parts of the body including the face, hands, feet, genitals, abdomen, and airways. While HAE ...

In a small clinical trial, Intellia’s NTLA-2002 gene therapy based on CRISPR/Cas9 demonstrated promise in treating hereditary angioedema, a rare genetic condition that causes swelling of the skin, gut ...

Hereditary angioedema (HAE) is a genetic syndrome caused by a functional deficit in complement C1 inhibitor that results in recurrent episodes of nonpruritic swelling of the hands, feet, arms, legs, ...